The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...
Dividend growth stocks offer a balance of stability and compounding returns, and here are three standout companies with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback